Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CanSino

Vaccine-Maker CanSino Bio Plans Swiss Listing

The company, which has developed multiple Covid-19 vaccines, aims to tap new international financing and boost its global brand

Caixin Global · Jan 11, 2023

CanSino's Omicron mRNA shot reports 'positive' trial data

CanSino's Omicron mRNA shot reports 'positive' trial data

Chinese officials say they have "safe and effective" vaccines as Beijing rebuffs mRNA shots from the U.S. and the EU.

Fortune · Jan 9, 2023

China's inhaled Covid vaccine approved 'offering protection after one breath'

China's inhaled Covid vaccine approved 'offering protection after one breath'

Made by CanSino, it has similar ingredients to its injected vaccine, using a harmless adenovirus as a carrier for the genetic code that teaches the body how to fight Covid.

Daily Mirror · Sep 5, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

CanSino's inhaled Covid-19 vaccine gets emergency use approval in China

HONG KONG: China's CanSino Biologics Inc said on Sunday that its recently developed Covid-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.

Bangkok Post · Sep 4, 2022

CanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?

Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO The approval could have limited benefits for the company as the pandemic fades and other products are widely available By Jony Ho

Benzinga · May 26, 2022

CanSino Shares Jump After WHO Gives Nod to Its Covid-19 Vaccine

Tianjin-based company’s stock closes up 12.14% in Shanghai and 9.78% in Hong Kong

Caixin Global · May 20, 2022

1

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

423,993 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play